Novo Nordisk raised its financial outlook as it tries to catch up with rival Eli Lilly in the booming GLP-1 market.
سيظهر الملخص التحليلي هنا بعد اكتمال معالجة الذكاء الاصطناعي.
Novo Nordisk raised its financial outlook as it tries to catch up with rival Eli Lilly in the booming GLP-1 market.
فتح الخبر الأصلي
الأعمال
The company didn't provide updated guidance. New CEO Silvio Napoli earlier this year suspended production expectations.
اقرأ المزيد ←
الأعمال
Paramount Skydance reported second-quarter earnings after the bell and said it continues to prepare for its proposed merger with Warner Bros. Discovery.
اقرأ المزيد ←
الأعمال
Chipotle has pulled the affected supply from restaurants and replaced them with peppers from different growers, according to the company.
اقرأ المزيد ←
الأعمال
P&G CEO Shailesh Jejurikar said the acquisition is play to grow the company's health business on CNBC's "Squawk on the Street."
اقرأ المزيد ←